HIV Mutation Detail Information

> M184V Search Result


Mutation Information
Mutation Site M184V
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug lamivudine (LAM);abacavir (ABC)
Country Indian
Literature Information
PubMed PMID 33390085
Disease HIV infection/AIDS
Published Year 2021
Journal AIDS research and human retroviruses
Title Detection of Drug Resistance Mutations in the Reverse Transcriptase Gene of HIV-1-Infected North Indian Population Failing First-Line Antiretroviral Therapy "A Follow-Up Cohort Study".
Author Barik SK,Bansal AK,Mohanty PS,Tripathy SP,Hanna LE,Karunaianantham R,Pattabiraman S,Singh TP,Tandon R,Tomar S,Jena S,Patil SA,Mohanty KK
Evidence Drug resistance mutation M184V (ATG to GTA) (63.15%) associated with lamivudine and abacavir and K103N (AAG or AAA to AAU) (36.84%) associated with efavirenz and nevirapine were predominantly identified in first line ART failure patients.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation